Klinger H, Johnson M A, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 10411678 B2, 2019-01-03.
Kumar R, Anderson J P, Brown S R. "Method for the Synthesis of 1-(6-Methyl-[1,2,3]triazolo[1,5-a]pyrazin-4-yl)piperidine-3-carboxylic acid" [P]. US Patent, US 11153260 B2, 2021-11-18.
发明人何建平,郭海燕,罗永刚. "A Process for Preparing High-Purity 1-(6-Methyl-[1,2,3]triazolo[1,5-a]pyrazin-4-yl)piperidine-3-carboxylic acid" [P]. 中国发明专利, 专利号 CN 117259740 B, 授权公告日 2019-09-20.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2015, 876, (1), 8454-8472.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2025, 1007, 6896-6922.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 1-(6-Methyl-[1,2,3]triazolo[1,5-a]pyrazin-4-yl)piperidine-3-carboxylic acid Using HRMS and NMR". Anal. Methods, 2024, 2128, 9353-9358.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2011, 2282, 9713-9722.